INS and neoplasm: As breast tumors often express higher levels of the IGF-1 receptor [51–54], it is of no surprise that insulin and IFG-1 have been correlated with early recurrence and decreased relapse-free survival in breast cancer as well as increased resistance of tumor cells to both chemotherapy and radiation therapy [45, 46].